Protagonist Therapeutics Inc.
PTGX | NASDAQ
$144.98
+$1.98 (+1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$144.80
-$0.18 (-0.12%)
Pre-market:
Sep 22, 2026, 8:20 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 128.39M | 97.25M | 186.73M | 125.74M | 123.67M | 117.36M |
Short-Term Investments | 438.97M | 321.66M | 154.89M | 111.61M | 203.24M | 188.45M |
Long-Term Investments | 78.93M | 140.25M | n/a | n/a | n/a | 2M |
Other Long-Term Assets | n/a | 225K | 225K | 225K | 225K | 450K |
Receivables | 4.5M | 168.49M | 10.33M | 52K | 5.33M | 3.82M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | 10K |
Total Current Assets | 577.57M | 591.64M | 355.58M | 243.08M | 340.74M | 315.61M |
Property-Plant & Equipment | 11.69M | 12.61M | 2.15M | 4.63M | 6.73M | 6.41M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 92.32M | 153.08M | 2.37M | 4.85M | 6.96M | 8.86M |
Total Assets | 669.89M | 744.73M | 357.95M | 247.93M | 347.7M | 324.47M |
Account Payables | 5.34M | 1.62M | 772K | 3.64M | 1.6M | 3.08M |
Deferred Revenue | 9.55M | 18.89M | n/a | 69K | 2.5M | 17.21M |
Short-Term Debt | 2.28M | 510K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 15.51M | 12.62M | 6.79M | 4.97M | 7.13M | 6.41M |
Total Current Liabilities | 45.44M | 47.4M | 21.27M | 31.18M | 44.02M | 40.24M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 11.68M | -221K | n/a | n/a | 121K |
Total Long-Term Liabilities | 9.74M | 22.03M | n/a | 1.14M | 3.66M | 4.62M |
Total Liabilities | 55.19M | 69.43M | 21.27M | 32.32M | 47.67M | 44.86M |
Total Debt | 10.32M | 10.87M | 1.14M | 3.66M | 5.86M | 5.96M |
Book Value | 614.71M | 675.3M | 336.68M | 215.61M | 300.02M | 279.61M |
Book Value Per Share | 9.67 | 10.38 | 5.93 | 4.40 | 6.48 | 8.13 |
Common Stock | 1K | 1K | 1K | n/a | n/a | n/a |
Retained Earnings | -470.67M | -340.52M | -615.71M | -536.76M | -409.36M | -283.81M |
Comprehensive Income | 641K | -82K | -105K | -359K | -299K | 28K |
Shareholders Equity | 614.71M | 675.3M | 336.68M | 215.61M | 300.02M | 279.61M |
Total Investments | 517.9M | 461.92M | 154.89M | 111.61M | 203.24M | 190.45M |
Add to Watchlist
Select watchlists to add or remove PTGX